-
Forward Look
The Late Effects of Childhood CancerAlmost all childhood cancer survivors will develop significant health problems related to their treatment by age 45.
by Suzanne McBride
-
Forward Look
Non-surgical Options in Bladder CancerSome people with muscle-invasive cancer can forgo bladder removal surgery.
by Darcy Lewis
-
From the Editor-in-Chief
Early-onset Colorectal Cancer on the RiseResearchers search for reasons for the growing number of cases in people under 50.
by William G. Nelson, MD, PhD
-
CAR T-cell Therapy: Understanding the Warning and the Risks
The FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
The More You Know About Cancer Prevention
Studies found awareness gaps about cancer prevention strategies such as screening and vaccination may reduce benefits from these tactics.
by Cancer Research Catalyst
-
Emerging Treatments for Brain Metastases in Breast Cancer
SABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
-
From the Editor-in-Chief
Cancer Treatment: Can Less Be More?Molecular profiling that has led to spectacular advances in cancer treatment may also improve cancer survivorship.
by William G. Nelson, MD, PhD
-
Forward Look
A Closer Look at Stress and Cancer OutcomesSurgical oncologist Samilia Obeng-Gyasi describes research that shows chronic stress is associated with higher mortality in cancer.
by Ashley P. Taylor
-
Forward Look
CDK4/6 Inhibitors in Early-stage Breast CancerA mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
by Darcy Lewis
-
Forward Look
Is Immunotherapy Safe in People With HIV?Study supports the use of immune checkpoint inhibitors in an understudied population.
by Carolyn Bernhardt
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona